
Temsirolimus: Is Improved Survival the Correct Expression of Drug Activity?
Author(s) -
Basso Michele,
Cassano Alessandra,
Schinzari Giovanni,
Barone Carlo
Publication year - 2010
Publication title -
the oncologist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1634/theoncologist.2010-0099
Subject(s) - medicine , temsirolimus , drug , oncology , pharmacology , anticancer drug , expression (computer science) , cancer research , bioinformatics , computational biology , discovery and development of mtor inhibitors , genetics , pi3k/akt/mtor pathway , apoptosis , biology , computer science , programming language
The article comments on the drug approval summary for temsirolimus published recently in The Oncologist in regard to the difference observed between the investigators' and independent reviewers' assessments.